Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
3.73M
-
Number of holders
-
7
-
Total 13F shares, excl. options
-
152K
-
Shares change
-
+120K
-
Total reported value, excl. options
-
$196K
-
Value change
-
+$155K
-
Number of buys
-
6
-
Number of sells
-
-3
-
Price
-
$1.29
Significant Holders of 60 Degrees Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share (SXTP) as of Q4 2024
10 filings reported holding SXTP - 60 Degrees Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share as of Q4 2024.
60 Degrees Pharmaceuticals, Inc. - Common stock, par value $0.0001 per share (SXTP) has 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 152K shares
of 3.73M outstanding shares and own 4.09% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (98.9K shares), UBS Group AG (20.4K shares), TWO SIGMA SECURITIES, LLC (15.4K shares), HRT FINANCIAL LP (12.6K shares), Tower Research Capital LLC (TRC) (3.73K shares), Safe Harbor Fiduciary, LLC (1.38K shares), OSAIC HOLDINGS, INC. (500 shares), BANK OF AMERICA CORP /DE/ (13 shares), NATIONAL BANK OF CANADA /FI/ (0 shares), and CITADEL ADVISORS LLC (0 shares).
This table shows the top 7 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.